Redefining immunotherapy

Developing immune therapies across human health

From COVID-19 to Cancer

  • Enabling knowledge-based prioritization and prosecution of target opportunities in the growing immunotherapy space

  • Translating viable target concepts into high quality drug development programs

  • Curing high unmet need diseases caused by imbalance in immunity

Incubating in stealth mode

FOCUS AREAS: INFECTIOUS DISEASES, AUTOIMMUNITY, CANCER

science operations at founderyinnovations dot com